Ferhina S. Ali, MD, discussed the real-world efficacy and durability of next-generation anti-VEGF agents like faricimab and aflibercept 8 mg, emphasizing how large-scale data offers insights into their performance and safety beyond clinical trials.
Ferhina S. Ali, MD, MPH
Advertisement
Vitreoretinal Specialist
Westchester Medical Center
Assistant Professor, New York Medical College
Valhalla, New York
Articles by Ferhina S. Ali, MD, MPH
Advertisement
